Compare Procter & Gamble Health with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ABBOTT INDIA - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ABBOTT INDIA PROCTER & GAMBLE HEALTH/
ABBOTT INDIA
 
P/E (TTM) x 52.7 48.2 109.4% View Chart
P/BV x 4.8 13.8 34.6% View Chart
Dividend Yield % 9.9 0.5 1,987.0%  

Financials

 PROCTER & GAMBLE HEALTH   ABBOTT INDIA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ABBOTT INDIA
Mar-18
PROCTER & GAMBLE HEALTH/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,5496,110 58.1%   
Low Rs1,3013,996 32.6%   
Sales per share (Unadj.) Rs511.41,552.2 32.9%  
Earnings per share (Unadj.) Rs61.3188.8 32.5%  
Cash flow per share (Unadj.) Rs74.0196.4 37.7%  
Dividends per share (Unadj.) Rs440.0055.00 800.0%  
Dividend yield (eoy) %18.11.1 1,666.9%  
Book value per share (Unadj.) Rs927.8796.6 116.5%  
Shares outstanding (eoy) m16.6021.25 78.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.73.3 145.7%   
Avg P/E ratio x39.626.8 147.8%  
P/CF ratio (eoy) x32.825.7 127.4%  
Price / Book Value ratio x2.66.3 41.2%  
Dividend payout %717.929.1 2,464.4%   
Avg Mkt Cap Rs m40,257107,376 37.5%   
No. of employees `0001.13.3 34.1%   
Total wages/salary Rs m1,3133,937 33.3%   
Avg. sales/employee Rs Th7,486.79,929.3 75.4%   
Avg. wages/employee Rs Th1,157.61,185.1 97.7%   
Avg. net profit/employee Rs Th897.21,207.7 74.3%   
INCOME DATA
Net Sales Rs m8,49032,985 25.7%  
Other income Rs m2441,170 20.8%   
Total revenues Rs m8,73434,155 25.6%   
Gross profit Rs m1,4825,245 28.2%  
Depreciation Rs m211162 130.5%   
Interest Rs m038 0.0%   
Profit before tax Rs m1,5146,215 24.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5632,203 25.5%   
Profit after tax Rs m1,0174,012 25.4%  
Gross profit margin %17.515.9 109.7%  
Effective tax rate %37.135.4 104.8%   
Net profit margin %12.012.2 98.5%  
BALANCE SHEET DATA
Current assets Rs m15,34322,655 67.7%   
Current liabilities Rs m1,9606,681 29.3%   
Net working cap to sales %157.648.4 325.5%  
Current ratio x7.83.4 230.8%  
Inventory Days Days4965 75.2%  
Debtors Days Days2829 97.6%  
Net fixed assets Rs m1,209835 144.7%   
Share capital Rs m166213 78.1%   
"Free" reserves Rs m15,23516,715 91.1%   
Net worth Rs m15,40116,928 91.0%   
Long term debt Rs m00-   
Total assets Rs m17,59524,162 72.8%  
Interest coverage xNM163.7-  
Debt to equity ratio x00-  
Sales to assets ratio x0.51.4 35.3%   
Return on assets %5.816.8 34.5%  
Return on equity %6.623.7 27.9%  
Return on capital %10.336.9 27.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,636369 444.0%   
Fx outflow Rs m4,3683,807 114.8%   
Net fx Rs m-2,732-3,438 79.5%   
CASH FLOW
From Operations Rs m-1,3041,527 -85.4%  
From Investments Rs m12,697-2,148 -591.0%  
From Financial Activity Rs m-301-1,024 29.3%  
Net Cashflow Rs m11,093-1,646 -674.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 7.9 230.4%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.1 170.2%  
Shareholders   28,591 18,270 156.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 14, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - SHASUN PHARMA COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS